Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis
Authors
Keywords
Ulcerative colitis, siRNA, Nanomicelle, functional peptide, Systemic delivery, NF- κB
Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 170, Issue -, Pages 170-178
Publisher
Elsevier BV
Online
2021-12-25
DOI
10.1016/j.ejpb.2021.12.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA
- (2021) Misako Kawai et al. MOLECULAR PHARMACEUTICS
- In Vivo Fluorescence Imaging of Passive Inflammation Site Accumulation of Liposomes via Intravenous Administration Focused on Their Surface Charge and PEG Modification
- (2021) Hisako Ibaraki et al. Pharmaceutics
- Macrophage-based nanotherapeutic strategies in ulcerative colitis
- (2020) Jiaxin Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles
- (2020) Hisako Ibaraki et al. Pharmaceutics
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis
- (2019) Hisako Ibaraki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
- (2019) Takanori Kanazawa et al. Pharmaceutics
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide
- (2018) Hisako Ibaraki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Improving siRNA Delivery In Vivo Through Lipid Conjugation
- (2018) Maire F. Osborn et al. Nucleic Acid Therapeutics
- Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis
- (2018) Yuzhe Huang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes
- (2017) Mitsuo Otsuka et al. EXPERIMENTAL LUNG RESEARCH
- Adverse Reactions to Biologic Therapy
- (2017) Sheenal V. Patel et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide
- (2017) Takanori Kanazawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis
- (2017) Mingzhen Zhang et al. Nanomedicine
- Altered expression of Tumor Necrosis Factor Alpha -Induced Protein 3 correlates with disease severity in Ulcerative Colitis
- (2017) Ishani Majumdar et al. Scientific Reports
- RNA interference-based nanosystems for inflammatory bowel disease therapy
- (2016) Jian Guo et al. International Journal of Nanomedicine
- Systemic delivery of small interfering RNA targeting nuclear factor κB in mice with collagen-induced arthritis using arginine-histidine-cysteine based oligopeptide-modified polymer nanomicelles
- (2016) Takanori Kanazawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effect of particle size on their accumulation in an inflammatory lesion in a dextran sulfate sodium (DSS)-induced colitis model
- (2016) Ayaka Watanabe et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Drug delivery to macrophages: Challenges and opportunities
- (2016) Yihua Pei et al. JOURNAL OF CONTROLLED RELEASE
- Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide
- (2016) Hisako Ibaraki et al. MOLECULES
- Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
- (2016) Bo Xiao et al. Theranostics
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis
- (2015) Takanori Kanazawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease
- (2015) Hidetoshi Takedatsu WORLD JOURNAL OF GASTROENTEROLOGY
- Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis
- (2015) Takanori Kanazawa et al. Pharmaceutics
- Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
- (2013) Bo Xiao et al. BIOMATERIALS
- Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies
- (2013) F. Talaei et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis
- (2013) Ana Beloqui et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery
- (2013) Ko Tanaka et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system
- (2013) J. McCarthy et al. JOURNAL OF CONTROLLED RELEASE
- The Therapeutic Effect of Chelidonic Acid on Ulcerative Colitis
- (2012) Dae-Seung Kim et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium
- (2011) Kenji Suzuki et al. PATHOLOGY INTERNATIONAL
- Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
- (2010) Fernando Magro et al. BIODRUGS
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
- (2010) D. Scott Wilson et al. NATURE MATERIALS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started